IBM Complimentary Metal-Oxide Semiconductor (CMOS)
- Licensing agreement with IBM Research for use of its metal-oxide semi-conductive (CMOS) compatible nanosensors.
- Gives the potential to provide and objective and real-time assessment of injury or infection at a greater sensitivity and specificity than other traditional point-of-care (POC) tests.
*The NanoDxTM System has not been evaluated by the FDA or other regulatory agencies.
